Philip Mazzara Sells 4,849 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 4,849 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total value of $600,306.20. Following the sale, the general counsel directly owned 138,084 shares of the company’s stock, valued at $17,094,799.20. This represents a 3.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Astera Labs Stock Down 2.2%

ALAB stock opened at $129.68 on Friday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market cap of $21.90 billion, a P/E ratio of 106.30, a PEG ratio of 2.61 and a beta of 1.50. The business’s 50-day moving average price is $160.40 and its 200-day moving average price is $174.06.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period in the prior year, the firm posted $0.37 EPS. The firm’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ALAB. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Astera Labs by 21.6% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after purchasing an additional 2,624 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after acquiring an additional 53,276 shares during the last quarter. Harbour Investments Inc. raised its stake in shares of Astera Labs by 207.7% in the second quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock valued at $221,000 after acquiring an additional 1,651 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Astera Labs by 34.5% in the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock valued at $47,208,000 after acquiring an additional 133,961 shares during the period. Finally, Corient Private Wealth LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth about $543,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
  • Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
  • Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
  • Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
  • Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
  • Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
  • Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
  • Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on ALAB shares. Roth Mkm upped their target price on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $192.89.

Get Our Latest Research Report on ALAB

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.